SRNE News and Press, Sorrento Therapeutics Inc. From 02/18/23

3 Tips for Selling Penny Stocks in 2023 Penny stocks are stocks that are typically priced below $5 per share and offer significant upside potential for investors. Many people are drawn to penny stocks because of their low cost and the potential for high returns. However, penny stocks can ...

SAN DIEGO, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted an update to its previously issued “Frequently Asked Questions” document under the “Investors” section of its website at www.sorrentothera...

Robinhood has become one of the popular platforms used by retail traders. A popular group of stocks that has remained attractive is the ones trading for under $5. Whether you call them “ penny stocks ” or simply “cheap stocks,” the term is secondary to why they...

3 Ways to Identify Penny Stock Trends Penny stocks can offer significant upside potential for investors who are willing to take on some risk. However, penny stocks can also be highly volatile, which makes it challenging to identify trends and make informed investment decisions. For this r...

Sorrento Therapeutics, Inc. Receives Court Approval for "First Day" Employee Wages and Cash Management Motions PR Newswire SAN DIEGO , Feb. 16, 2023 /PRNewswire/ -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a biopharmaceutical company dedicated to t...

Scilex Holding Co. ( NASDAQ: SCLX ), a majority-owned subsidiary of Sorrento Therapeutics ( NASDAQ: SRNE ), is not a debtor in the latter's Chapter 11 bankruptcy filing announced earlier on Monday. The two companies said that business will continue as usual at Scilex ( S...

SAN DIEGO and PALO ALTO, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) and an innovative revenue-generating company focused on acquiring, ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sorrento Therapeutics (NASDAQ: SRNE ) is down by more than 60% today following the company’s announcement that it would file for Chapter 11 bankruptcy . Scintilla Pharmaceuticals , a wholly owned subsidiary of So...

Shares of the commercial-stage biopharma Sorrento Therapeutics (NASDAQ: SRNE) are having a tough time today. Specifically, the drugmaker's stock is down by a hefty 56.3% as of 11:22 a.m. Monday morning. What's sparking this dramatic sell-off? Ahead of the opening bell, Sorrento releas...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Monday.com (NASDAQ: MNDY ) stock is on the rise Monday after announcing a partnership with Appfire to expand its app marketplace. As part of this partnership, Appfire will build out the Mo...